Viridian Therapeutics Inc

NASDAQ: VRDN
Share price (5/1/24): $13.81
Market cap (5/1/24): $881 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

ended 12/31/22 FY 2022

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Automatic shelf registration

Registration of securities for employees

Ownership Filter

Fairmount Funds Management LLC

Fairmount Healthcare Fund L.P., Fairmount Healthcare Fund II L.P., Fairmount Funds Management LLC, Fairmount Healthcare Fund II GP LLC, Fairmount Healthcare Fund GP LLC

Commodore Capital LP

Deep Track Capital, LP

Venrock Healthcare Capital Partners III, L.P.

News Filter

Material Definitive Agreement

Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results

Material Definitive Agreement, Earnings Release or Operating Update, Other Events, Financial Statements or Exhibits

To Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference

Announces Positive Clinical Data in Healthy Volunteer Study and Selects VRDN-003 as Potential Best-In-Class Subcutaneous Anti-Igf-1r Program With Extended Half-Life for Pivotal Development in Thyroid Eye Disease

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC